Kojic acid soap sold in the United States is regulated as a cosmetic under the Federal Food, Drug, and Cosmetic Act (FD&C Act), administered by the FDA. As a cosmetic, it does not require pre-market approval, but it must be safe for its intended use, properly labeled, and manufactured under conditions that prevent contamination.
The FDA does not currently have an OTC drug monograph that permits kojic acid as an approved skin-lightening active in the way it once did for hydroquinone. This means kojic acid soap stays on the cosmetic side of the drug/cosmetic line — and where that line is drawn depends entirely on the claims you make.
Cosmetic claims that are generally safe for kojic acid soap include: brightens the appearance of skin, reduces the look of dark spots, evens skin tone, promotes a more radiant complexion, and visibly reduces the appearance of uneven pigmentation. These are appearance-based, not structure-or-function claims.
Drug claims that would cause the FDA to classify your product as an unapproved new drug include: treats melasma, eliminates hyperpigmentation, treats post-inflammatory hyperpigmentation (PIH), lightens skin, or inhibits melanin production. Even physiologically accurate language like melanin inhibitor can trigger drug-claim scrutiny because it implies an effect on a body function.
Proposition 65 in California is a separate consideration. The California Office of Environmental Health Hazard Assessment (OEHHA) added kojic acid to the Prop 65 list as a developmental and reproductive toxicant. Whether a warning is required depends on the daily exposure from your product — for a rinse-off soap, the exposure calculation often falls below the no-significant-risk level (NSRL), but you should have a qualified toxicologist or regulatory consultant run the numbers before selling into California without a warning.
If you plan to export to the EU, kojic acid is permitted up to 1% in face products and 0.5% in body lotions under EU Cosmetics Regulation Annex III. For soap, its rinse-off classification often gives some flexibility, but you'll need a European Responsible Person and a compliant Product Information File (PIF) before selling in EU markets.
The most common mistake indie founders make is copying label language from a competitor without verifying that competitor is actually in compliance. FDA enforcement in cosmetics is complaint-driven and varies, but a warning letter or import alert — especially as your brand scales — can cost far more than getting it right at launch. Work with a regulatory consultant or cosmetic chemist who reviews label copy as part of their service scope.
Ingredients in this answer: Kojic Acid
Read the full guide on Private Label Kojic Acid Soap Manufacturer USA Low MOQ →